Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-18-009114
Filing Date
2018-06-28
Accepted
2018-06-28 19:43:37
Documents
1
Period of Report
2018-06-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 6196
  Complete submission text file 0001179110-18-009114.txt   7681
Mailing Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Issuer) CIK: 0001651308 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE CAMANA BAY, GRAND CAYMAN E9 KY1-1108
Business Address
Liang Howard (Reporting) CIK: 0001663427 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37686 | Film No.: 18926808